Name: Latest research reports of Aarti Drugs Ltd. authored by Axis Direct and published by - Trendlyne research reports.
Item: Aarti Drugs Ltd.
Rating: 5
Author: Axis Direct

Aarti Drugs Ltd.

NSE: AARTIDRUGS | BSE: 524348 | ISIN: INE767A01016 | Industry: Pharmaceuticals
| Mid-range Performer

499.0500 -0.25 (-0.05%)

NSE Oct 07, 2025 12:28 PM

59.95% Gain from 52W Low

Volume: 34,186

Aarti Drugs Ltd.

20 May 2024

499.05

-0.05%

Pick of the Week:21 MAY 2024

Buy: Aarti Drugs Ltd.

Target

Axis Direct

We recommend a BUY rating on the stock with a target price of Rs 536/share, implying an upside of 10% from CMP

Aarti Drugs Ltd. has an average target of 475.00 from 1 broker.